November 05, 2024 2 min read ...
November 04, 2024 2 min read ...
October 29, 2024 2 min read ...
October 29, 2024 2 min read ...
The 5-year survival for pancreatic ductal adenocarcinoma (PDAC) exceeds 74% if diagnosed at stage I; however, this represents just 12% of resected cases.1 ...
Pancreatic endocrine cells are systematically altered in pancreatic ductal adenocarcinoma, defined as cancer-associated endocrine cells, in which pancreatic ...
The relationship between pancreatic ductal adenocarcinoma (PDAC) and diabetes mellitus (DM) is well known. However, recent studies reveal more extensive, ...
Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive cancer with limited treatment options and a 5-year survival rate of just 12.8%.1 Early ...
The recent review on pancreas is extremely timely, succinct, and highly informative.1 The investigators are leaders in the field with seminal contributions ...
Patient-derived organoids (PDO) are promising tumor avatars that could enable ex vivo drug tests to personalize patients’ treatment in the frame of ...
- 1
- 2
- 3
- …
- 5
- Next Page »